{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T13:13:33Z","timestamp":1794662013922,"version":"4.9.1"},"reference-count":197,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:00Z","timestamp":1752537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:00Z","timestamp":1752537600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Science and Technology Program of Guangzho"},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U23A20445"],"award-info":[{"award-number":["U23A20445"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Oral Sci"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Radiochemotherapy-induced oral mucositis (OM) is a common oral complication in patients with tumors following head and neck radiotherapy or chemotherapy. Erosion and ulcers are the main features of OM that seriously affect the quality of life of patients and even the progress of tumor treatment. To date, differences in clinical prevention and treatment plans for OM have been noted among doctors of various specialties, which has increased the uncertainty of treatment effects. On the basis of current research evidence, this expert consensus outlines risk factors, clinical manifestations, clinical grading, ancillary examinations, diagnostic basis, prevention and treatment strategies and efficacy indicators for OM. In addition to strategies such as basic oral care, anti-inflammatory and analgesic agents, anti-infective agents, pro-healing agents, and photobiotherapy recommended in previous guidelines, we also emphasize the role of traditional Chinese medicine in OM prevention and treatment. This expert consensus aims to provide references and guidance for dental physicians and oncologists in formulating strategies for OM prevention, diagnosis, and treatment, standardizing clinical practice, reducing OM occurrence, promoting healing, and improving the quality of life of patients.<\/jats:p>","DOI":"10.1038\/s41368-025-00382-8","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T09:06:35Z","timestamp":1752570395000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Expert consensus on the prevention and treatment of radiochemotherapy-induced oral mucositis"],"prefix":"10.1038","volume":"17","author":[{"given":"Juan","family":"Xia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoan","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinchao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuzhen","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoyao","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7455-9083","authenticated-orcid":false,"given":"Tong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5371-4432","authenticated-orcid":false,"given":"Qianming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobing","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaosu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongmei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemin","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renchuan","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenmei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingfang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minhai","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiufeng","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1124-4548","authenticated-orcid":false,"given":"Yongzhan","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changqing","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,15]]},"reference":[{"key":"382_CR1","first-page":"57","volume":"72","author":"S Elad","year":"2022","unstructured":"Elad, S., Yarom, N., Zadik, Y., Kuten-Shorrer, M. & Sonis, S. T. The broadening scope of oral mucositis and oral ulcerative mucosal toxicities of anticancer therapies. Ca. Cancer J. Clin. 72, 57\u201377 (2022).","journal-title":"Ca. Cancer J. Clin."},{"key":"382_CR2","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1097\/CAD.0b013e3283462086","volume":"22","author":"ST Sonis","year":"2011","unstructured":"Sonis, S. T. Oral mucositis. Anticancer. Drugs 22, 607\u2013612 (2011).","journal-title":"Anticancer. Drugs"},{"key":"382_CR3","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1200\/JCO.2001.19.8.2201","volume":"19","author":"ST Sonis","year":"2001","unstructured":"Sonis, S. T. et al. Oral Mucositis and the Clinical and Economic Outcomes of Hematopoietic Stem-Cell Transplantation. J. Clin. Oncol. 19, 2201\u20132205 (2001).","journal-title":"J. Clin. Oncol."},{"key":"382_CR4","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.1002\/cncr.20163","volume":"100","author":"EB Rubenstein","year":"2004","unstructured":"Rubenstein, E. B. et al. Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis. Cancer 100, 2026\u20132046 (2004).","journal-title":"Cancer"},{"key":"382_CR5","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1002\/cncr.22484","volume":"109","author":"DM Keefe","year":"2007","unstructured":"Keefe, D. M. et al. Updated clinical practice guidelines for the prevention and treatment of mucositis. Cancer 109, 820\u2013831 (2007).","journal-title":"Cancer"},{"key":"382_CR6","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1002\/cncr.28592","volume":"120","author":"RV Lalla","year":"2014","unstructured":"Lalla, R. V. et al. MASCC\/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer 120, 1453\u20131461 (2014).","journal-title":"Cancer"},{"key":"382_CR7","doi-asserted-by":"publisher","first-page":"4423","DOI":"10.1002\/cncr.33100","volume":"126","author":"S Elad","year":"2020","unstructured":"Elad, S. et al. MASCC\/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer 126, 4423\u20134431 (2020).","journal-title":"Cancer"},{"key":"382_CR8","doi-asserted-by":"publisher","first-page":"vi78","DOI":"10.1093\/annonc\/mdr391","volume":"22","author":"DE Peterson","year":"2011","unstructured":"Peterson, D. E., Bensadoun, R.-J. & Roila, F. Management of oral and gastrointestinal mucositis: ESMO Clinical Practice Guidelines. Ann. Oncol. 22, vi78\u2013vi84 (2011).","journal-title":"Ann. Oncol."},{"key":"382_CR9","doi-asserted-by":"crossref","unstructured":"Riley, P. et al. Interventions for preventing oral mucositis in patients with cancer receiving treatment: cytokines and growth factors. Cochrane Database Syst. Rev. 11, CD011990 (2017).","DOI":"10.1002\/14651858.CD011990.pub2"},{"key":"382_CR10","first-page":"641","volume":"28","author":"Chinese Society of Radiation Oncology of Chinese Medical Association","year":"2019","unstructured":"Chinese Society of Radiation Oncology of Chinese Medical Association Expert consensus on prevention and control strategy of radiotherapy\u2043induced oral mucositis (2019). Chin. J. Radiat. Oncol. 28, 641\u2013647 (2019).","journal-title":"Chin. J. Radiat. Oncol."},{"key":"382_CR11","unstructured":"ASMC in CSCO, SCRC. Expert consensus on diagnosis and prevention of acute oral mucositis caused by antitumor therapy. Chin. Clin. Oncol. 26, 449\u2013459 (2021)."},{"key":"382_CR12","doi-asserted-by":"crossref","unstructured":"Ghalayani, P., Emami, H., Pakravan, F. & Nasr Isfahani, M. Comparison of triamcinolone acetonide mucoadhesive film with licorice mucoadhesive film on radiotherapy-induced oral mucositis: A randomized double-blinded clinical trial. Asia Pac. J. Clin. Oncol. 13, e48\u2013e56 (2017).","DOI":"10.1111\/ajco.12295"},{"key":"382_CR13","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.ijom.2018.10.010","volume":"48","author":"Y Kawashita","year":"2019","unstructured":"Kawashita, Y. et al. Effectiveness of a comprehensive oral management protocol for the prevention of severe oral mucositis in patients receiving radiotherapy with or without chemotherapy for oral cancer: a multicentre, phase II, randomized controlled trial. Int. J. Oral. Maxillofac. Surg. 48, 857\u2013864 (2019).","journal-title":"Int. J. Oral. Maxillofac. Surg."},{"key":"382_CR14","unstructured":"Yingming, Z., Li, H. & Jiaxia, W. Clinical effect of Kouyanqing granules combined with recombinant bovine basic fibroblast growth factor on acute radiation stomatitis. Chin. Tradit. Pat. Med. 41, 478\u2013480 (2019)."},{"key":"382_CR15","unstructured":"Li, S. H., Jing, N. D. & Lu, H. Curative effect observation of Beifuji for radiation mucositis. Chin. J. Geriatr. Dent. 7, 262\u2013264 (2009)."},{"key":"382_CR16","first-page":"30","volume":"28","author":"J Li","year":"2018","unstructured":"Li, J. & Kai, Z. Clinical observation of recombinant bovine basic fibroblast growth factor in the prevention and treatment of radiation stomatitis. J. Baotou Med. Coll. 28, 30 (2018).","journal-title":"J. Baotou Med. Coll."},{"key":"382_CR17","first-page":"953","volume":"24","author":"K Harada","year":"2016","unstructured":"Harada, K. et al. Efficacy of elemental diet on prevention for chemoradiotherapy-induced oral mucositis in patients with oral squamous cell carcinoma. Support. Care Cancer 24, 953\u2013959 (2016).","journal-title":"Support. Care Cancer"},{"key":"382_CR18","doi-asserted-by":"publisher","first-page":"3561","DOI":"10.2169\/internalmedicine.55.7310","volume":"55","author":"T Morishita","year":"2016","unstructured":"Morishita, T. et al. The Efficacy of an Oral Elemental Diet in Patients Undergoing Hematopoietic Stem Cell Transplantation. Intern. Med. 55, 3561\u20133569 (2016).","journal-title":"Intern. Med."},{"key":"382_CR19","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.ijrobp.2017.10.013","volume":"100","author":"B Zheng","year":"2018","unstructured":"Zheng, B. et al. Randomized, Double-Blind, Placebo-Controlled Trial of Shuanghua Baihe Tablets to Prevent Oral Mucositis in Patients With Nasopharyngeal Cancer Undergoing Chemoradiation Therapy. Int. J. Radiat. Oncol. 100, 418\u2013426 (2018).","journal-title":"Int. J. Radiat. Oncol."},{"key":"382_CR20","doi-asserted-by":"publisher","unstructured":"Jun, C. et al. Clinical Analysis of Effect of Colchester Browns Lily on the Oral Mucositis of Patients with Head and Neck Neoplasm Caused by the Radiology Therapy. Syst. Med. 131\u2013133 https:\/\/doi.org\/10.19368\/j.cnki.2096-1782.2017.17.131. (2017)","DOI":"10.19368\/j.cnki.2096-1782.2017.17.131"},{"key":"382_CR21","unstructured":"Dong, K., Zhang, M., Liang, Y., Zhang, M. & Fei, X. Effects of Kangfuxin Solution on treatment of Severe Oral Mucositis in Patients with after Radiotherapy of Head and Neck Cancer and Its Protection Effect on Salivary Glands. World J. Integr. Tradit. West. Med. 16, 123\u2013127 (2021)."},{"key":"382_CR22","doi-asserted-by":"crossref","unstructured":"Luo, Y. et al. Effect of Kangfuxin Solution on Chemo\/Radiotherapy-Induced Mucositis in Nasopharyngeal Carcinoma Patients: A Multicenter, Prospective Randomized Phase III Clinical Study. Evid. Based Complement. Alternat. Med. 2016, 1\u20137 (2016).","DOI":"10.1155\/2016\/8692343"},{"key":"382_CR23","unstructured":"Cai, Y., Zhu, L. & Lin, J. Effect of Kangfuxin ice cube on prevention and treatment of radioactive oral mucositis of nasopharyngeal carcinoma. J. Nurs. Rehabil. 20, 68\u201371 (2021)."},{"key":"382_CR24","first-page":"505","volume":"14","author":"JA Jones","year":"2006","unstructured":"Jones, J. A. et al. Epidemiology of treatment-associated mucosal injury after treatment with newer regimens for lymphoma, breast, lung, or colorectal cancer. Support. Care Cancer 14, 505\u2013515 (2006).","journal-title":"Support. Care Cancer"},{"key":"382_CR25","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1002\/cncr.20162","volume":"100","author":"ST Sonis","year":"2004","unstructured":"Sonis, S. T. et al. Perspectives on cancer therapy-induced mucosal injury: Pathogenesis, measurement, epidemiology, and consequences for patients. Cancer 100, 1995\u20132025 (2004).","journal-title":"Cancer"},{"key":"382_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/378281","volume":"2014","author":"TM Haverman","year":"2014","unstructured":"Haverman, T. M. et al. Oral Complications in Hematopoietic Stem Cell Recipients: The Role of Inflammation. Mediators Inflamm. 2014, 1\u201318 (2014).","journal-title":"Mediators Inflamm."},{"key":"382_CR27","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.critrevonc.2016.01.010","volume":"100","author":"V De Sanctis","year":"2016","unstructured":"De Sanctis, V. et al. Mucositis in head and neck cancer patients treated with radiotherapy and systemic therapies: Literature review and consensus statements. Crit. Rev. Oncol. Hematol. 100, 147\u2013166 (2016).","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"382_CR28","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/S0167-8140(02)00404-8","volume":"66","author":"A Trotti","year":"2003","unstructured":"Trotti, A. et al. Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. Radiother. Oncol. 66, 253\u2013262 (2003).","journal-title":"Radiother. Oncol."},{"key":"382_CR29","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S0360-3016(00)00663-5","volume":"48","author":"KK Fu","year":"2000","unstructured":"Fu, K. K. et al. A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int. J. Radiat. Oncol. 48, 7\u201316 (2000).","journal-title":"Int. J. Radiat. Oncol."},{"key":"382_CR30","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1177\/0194599813509586","volume":"150","author":"VM Duarte","year":"2014","unstructured":"Duarte, V. M. et al. Comparison of Dental Health of Patients with Head and Neck Cancer Receiving IMRT vs Conventional Radiation. Otolaryngol. Neck Surg. 150, 81\u201386 (2014).","journal-title":"Otolaryngol. Neck Surg."},{"key":"382_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s13014-015-0561-y","volume":"10","author":"M Hoffmann","year":"2015","unstructured":"Hoffmann, M. et al. Long term results of postoperative Intensity-Modulated Radiation Therapy (IMRT) in the treatment of Squamous Cell Carcinoma (SCC) located in the oropharynx or oral cavity. Radiat. Oncol. 10, 251 (2015).","journal-title":"Radiat. Oncol."},{"key":"382_CR32","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.radonc.2015.12.008","volume":"118","author":"PB Romesser","year":"2016","unstructured":"Romesser, P. B. et al. Proton beam radiation therapy results in significantly reduced toxicity compared with intensity-modulated radiation therapy for head and neck tumors that require ipsilateral radiation. Radiother. Oncol. 118, 286\u2013292 (2016).","journal-title":"Radiother. Oncol."},{"key":"382_CR33","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.1200\/JCO.2006.08.057","volume":"24","author":"J Bourhis","year":"2006","unstructured":"Bourhis, J. et al. Phase III Randomized Trial of Very Accelerated Radiation Therapy Compared With Conventional Radiation Therapy in Squamous Cell Head and Neck Cancer: A GORTEC Trial. J. Clin. Oncol. 24, 2873\u20132878 (2006).","journal-title":"J. Clin. Oncol."},{"key":"382_CR34","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/lary.22434","volume":"122","author":"Z Wang","year":"2012","unstructured":"Wang, Z. et al. Protecting the oral mucosa in patients with oral tongue squamous cell carcinoma treated postoperatively with intensity-modulated radiotherapy: A randomized study. Laryngoscope 122, 291\u2013298 (2012).","journal-title":"Laryngoscope"},{"key":"382_CR35","first-page":"1713","volume":"25","author":"E Vigarios","year":"2017","unstructured":"Vigarios, E., Epstein, J. B. & Sibaud, V. Oral mucosal changes induced by anticancer targeted therapies and immune checkpoint inhibitors. Support. Care Cancer 25, 1713\u20131739 (2017).","journal-title":"Support. Care Cancer"},{"key":"382_CR36","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1046\/j.1365-2141.2000.02202.x","volume":"110","author":"AM Wardley","year":"2000","unstructured":"Wardley, A. M. et al. Prospective evaluation of oral mucositis in patients receiving myeloablative conditioning regimens and haemopoietic progenitor rescue. Br. J. Haematol. 110, 292\u2013299 (2000).","journal-title":"Br. J. Haematol."},{"key":"382_CR37","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1056\/NEJMoa1510016","volume":"373","author":"TK Choueiri","year":"2015","unstructured":"Choueiri, T. K. et al. Cabozantinib versus Everolimus in Advanced Renal-Cell Carcinoma. N. Engl. J. Med. 373, 1814\u20131823 (2015).","journal-title":"N. Engl. J. Med."},{"key":"382_CR38","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1056\/NEJMoa1009290","volume":"364","author":"JC Yao","year":"2011","unstructured":"Yao, J. C. et al. Everolimus for Advanced Pancreatic Neuroendocrine Tumors. N. Engl. J. Med. 364, 514\u2013523 (2011).","journal-title":"N. Engl. J. Med."},{"key":"382_CR39","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/S1470-2045(14)70472-3","volume":"15","author":"PM Ellis","year":"2014","unstructured":"Ellis, P. M. et al. Dacomitinib compared with placebo in pretreated patients with advanced or metastatic non-small-cell lung cancer (NCIC CTG BR.26): a double-blind, randomised, phase 3 trial. Lancet Oncol. 15, 1379\u20131388 (2014).","journal-title":"Lancet Oncol."},{"key":"382_CR40","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1016\/S1470-2045(14)70452-8","volume":"15","author":"SS Ramalingam","year":"2014","unstructured":"Ramalingam, S. S. et al. Dacomitinib versus erlotinib in patients with advanced-stage, previously treated non-small-cell lung cancer (ARCHER 1009): a randomised, double-blind, phase 3 trial. Lancet Oncol. 15, 1369\u20131378 (2014).","journal-title":"Lancet Oncol."},{"key":"382_CR41","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/S1470-2045(13)70102-5","volume":"14","author":"F Lordick","year":"2013","unstructured":"Lordick, F. et al. Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial. Lancet Oncol. 14, 490\u2013499 (2013).","journal-title":"Lancet Oncol."},{"key":"382_CR42","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/S1470-2045(11)70385-0","volume":"13","author":"T Ciuleanu","year":"2012","unstructured":"Ciuleanu, T. et al. Efficacy and safety of erlotinib versus chemotherapy in second-line treatment of patients with advanced, non-small-cell lung cancer with poor prognosis (TITAN): a randomised multicentre, open-label, phase 3 study. Lancet Oncol. 13, 300\u2013308 (2012).","journal-title":"Lancet Oncol."},{"key":"382_CR43","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1056\/NEJMoa022457","volume":"348","author":"SG O\u2019Brien","year":"2003","unstructured":"O\u2019Brien, S. G. et al. Imatinib Compared with Interferon and Low-Dose Cytarabine for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia. N. Engl. J. Med. 348, 994\u20131004 (2003).","journal-title":"N. Engl. J. Med."},{"key":"382_CR44","doi-asserted-by":"crossref","unstructured":"First-Line Crizotinib versus Chemotherapy in ALK -Positive Lung Cancer. N. Engl. J. Med. 373, 1582\u20131582 (2015).","DOI":"10.1056\/NEJMx150034"},{"key":"382_CR45","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1200\/JCO.2013.50.3961","volume":"32","author":"TE Hutson","year":"2014","unstructured":"Hutson, T. E. et al. Randomized Phase III Trial of Temsirolimus Versus Sorafenib As Second-Line Therapy After Sunitinib in Patients With Metastatic Renal Cell Carcinoma. J. Clin. Oncol. 32, 760\u2013767 (2014).","journal-title":"J. Clin. Oncol."},{"key":"382_CR46","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1016\/S1470-2045(15)00216-8","volume":"16","author":"C Tournigand","year":"2015","unstructured":"Tournigand, C. et al. Bevacizumab with or without erlotinib as maintenance therapy in patients with metastatic colorectal cancer (GERCOR DREAM; OPTIMOX3): a randomised, open-label, phase 3 trial. Lancet Oncol. 16, 1493\u20131505 (2015).","journal-title":"Lancet Oncol."},{"key":"382_CR47","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/nrc1318","volume":"4","author":"ST Sonis","year":"2004","unstructured":"Sonis, S. T. The pathobiology of mucositis. Nat. Rev. Cancer 4, 277\u2013284 (2004).","journal-title":"Nat. Rev. Cancer"},{"key":"382_CR48","doi-asserted-by":"publisher","first-page":"5813","DOI":"10.1038\/sj.onc.1206680","volume":"22","author":"T Criswell","year":"2003","unstructured":"Criswell, T., Leskov, K., Miyamoto, S., Luo, G. & Boothman, D. A. Transcription factors activated in mammalian cells after clinically relevant doses of ionizing radiation. Oncogene 22, 5813\u20135827 (2003).","journal-title":"Oncogene"},{"key":"382_CR49","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S0167-8140(02)00060-9","volume":"63","author":"JW Denham","year":"2002","unstructured":"Denham, J. W. & Hauer-Jensen, M. The radiotherapeutic injury \u2013 a complex \u2018wound\u2019. Radiother. Oncol. 63, 129\u2013145 (2002).","journal-title":"Radiother. Oncol."},{"key":"382_CR50","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/S0887-2333(03)00024-9","volume":"17","author":"\u0160 Man\u0306\u00e1kov\u00e1","year":"2003","unstructured":"Man\u0306\u00e1kov\u00e1, \u0160, Puttonen, K. A., Raasmaja, A. & M\u00e4nnist\u00f6, P. T. Ara-C induces apoptosis in monkey fibroblast cells. Toxicol. Vitr. 17, 367\u2013373 (2003).","journal-title":"Toxicol. Vitr."},{"key":"382_CR51","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1177\/154411130201300502","volume":"13","author":"ST Sonis","year":"2002","unstructured":"Sonis, S. T. The biologic role for nuclear factor-kappaB in disease and its potential involvement in mucosal injury associated with anti-neoplastic therapy. Crit. Rev. Oral. Biol. Med. Publ. Am. Assoc. Oral. Biol. 13, 380\u2013389 (2002).","journal-title":"Crit. Rev. Oral. Biol. Med. Publ. Am. Assoc. Oral. Biol."},{"key":"382_CR52","first-page":"1256","volume":"23","author":"PD Hall","year":"1995","unstructured":"Hall, P. D., Benko, H., Hogan, K. R. & Stuart, R. K. The influence of serum tumor necrosis factor-alpha and interleukin-6 concentrations on nonhematologic toxicity and hematologic recovery in patients with acute myelogenous leukemia. Exp. Hematol. 23, 1256\u20131260 (1995).","journal-title":"Exp. Hematol."},{"key":"382_CR53","first-page":"187","volume":"12","author":"S Kitada","year":"1996","unstructured":"Kitada, S., Krajewski, S., Miyashita, T., Krajewska, M. & Reed, J. C. Gamma-radiation induces upregulation of Bax protein and apoptosis in radiosensitive cells in vivo. Oncogene 12, 187\u2013192 (1996).","journal-title":"Oncogene"},{"key":"382_CR54","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1046\/j.0904-2512.2001.10012.x","volume":"31","author":"SOM De Sousa","year":"2002","unstructured":"De Sousa, S. O. M., Mesquita, R. A., Pinto, D. S. & Gutkind, S. Immunolocalization of c-Fos and c-Jun in human oral mucosa and in oral squamous cell carcinoma. J. Oral. Pathol. Med. 31, 78\u201381 (2002).","journal-title":"J. Oral. Pathol. Med."},{"key":"382_CR55","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S0092-8674(00)00116-1","volume":"103","author":"RJ Davis","year":"2000","unstructured":"Davis, R. J. Signal Transduction by the JNK Group of MAP Kinases. Cell 103, 239\u2013252 (2000).","journal-title":"Cell"},{"key":"382_CR56","first-page":"85","volume":"53","author":"W Billis","year":"1998","unstructured":"Billis, W., Fuks, Z. & Kolesnick, R. Signaling in and regulation of ionizing radiation-induced apoptosis in endothelial cells. Recent Prog. Horm. Res. 53, 85\u201392 (1998).","journal-title":"Recent Prog. Horm. Res."},{"key":"382_CR57","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1007\/s00535-002-1101-8","volume":"38","author":"S Bamba","year":"2003","unstructured":"Bamba, S. et al. Matrix metalloproteinase-3 secretion from human colonic subepithelial myofibroblasts: role of interleukin-17. J. Gastroenterol. 38, 548\u2013554 (2003).","journal-title":"J. Gastroenterol."},{"key":"382_CR58","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1080\/09629350020002895","volume":"9","author":"M Sasaki","year":"2000","unstructured":"Sasaki, M. et al. Differential regulation of metalloproteinase production, proliferation and chemotaxis of human lung fibroblasts by PDGF, Interleukin-1\u03b2 and TNF-\u03b1. Mediators Inflamm. 9, 155\u2013160 (2000).","journal-title":"Mediators Inflamm."},{"key":"382_CR59","doi-asserted-by":"publisher","first-page":"52901","DOI":"10.1074\/jbc.M307638200","volume":"278","author":"M Alikhani","year":"2003","unstructured":"Alikhani, M. et al. Lipopolysaccharides Indirectly Stimulate Apoptosis and Global Induction of Apoptotic Genes in Fibroblasts. J. Biol. Chem. 278, 52901\u201352908 (2003).","journal-title":"J. Biol. Chem."},{"key":"382_CR60","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1002\/cncr.24696","volume":"116","author":"S Sonis","year":"2010","unstructured":"Sonis, S., Treister, N., Chawla, S., Demetri, G. & Haluska, F. Preliminary characterization of oral lesions associated with inhibitors of mammalian target of rapamycin in cancer patients. Cancer 116, 210\u2013215 (2010).","journal-title":"Cancer"},{"key":"382_CR61","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/j.jaad.2019.12.031","volume":"88","author":"S Singer","year":"2023","unstructured":"Singer, S. et al. Cutaneous eruptions from ibrutinib resembling epidermal growth factor receptor inhibitor\u2013induced dermatologic adverse events. J. Am. Acad. Dermatol. 88, 1271\u20131281 (2023).","journal-title":"J. Am. Acad. Dermatol."},{"key":"382_CR62","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1634\/theoncologist.2011-0111","volume":"17","author":"CB Boers-Doets","year":"2012","unstructured":"Boers-Doets, C. B. et al. Oral Adverse Events Associated with Tyrosine Kinase and Mammalian Target of Rapamycin Inhibitors in Renal Cell Carcinoma: A Structured Literature Review. Oncologist 17, 135\u2013144 (2012).","journal-title":"Oncologist"},{"key":"382_CR63","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.oraloncology.2015.09.003","volume":"51","author":"A Yuan","year":"2015","unstructured":"Yuan, A. et al. Oral adverse events in cancer patients treated with VEGFR-directed multitargeted tyrosine kinase inhibitors. Oral. Oncol. 51, 1026\u20131033 (2015).","journal-title":"Oral. Oncol."},{"key":"382_CR64","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1097\/CCO.0000000000000290","volume":"28","author":"V Sibaud","year":"2016","unstructured":"Sibaud, V. et al. Dermatologic complications of anti-PD-1\/PD-L1 immune checkpoint antibodies. Curr. Opin. Oncol. 28, 254\u2013263 (2016).","journal-title":"Curr. Opin. Oncol."},{"key":"382_CR65","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.ejca.2016.02.025","volume":"60","author":"L Hofmann","year":"2016","unstructured":"Hofmann, L. et al. Cutaneous, gastrointestinal, hepatic, endocrine, and renal side-effects of anti-PD-1 therapy. Eur. J. Cancer 60, 190\u2013209 (2016).","journal-title":"Eur. J. Cancer"},{"key":"382_CR66","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1111\/cup.12666","volume":"43","author":"KB Schaberg","year":"2016","unstructured":"Schaberg, K. B. et al. Immunohistochemical analysis of lichenoid reactions in patients treated with anti-PD-L1 and anti-PD-1 therapy. J. Cutan. Pathol. 43, 339\u2013346 (2016).","journal-title":"J. Cutan. Pathol."},{"key":"382_CR67","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3389\/fonc.2017.00089","volume":"7","author":"OM Maria","year":"2017","unstructured":"Maria, O. M., Eliopoulos, N. & Muanza, T. Radiation-Induced Oral Mucositis. Front. Oncol. 7, 89 (2017).","journal-title":"Front. Oncol."},{"key":"382_CR68","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/hed.10326","volume":"26","author":"C Scully","year":"2004","unstructured":"Scully, C., Epstein, J. & Sonis, S. Oral mucositis: A challenging complication of radiotherapy, chemotherapy, and radiochemotherapy. Part 2: Diagnosis and management of mucositis. Head. Neck 26, 77\u201384 (2004).","journal-title":"Head. Neck"},{"key":"382_CR69","unstructured":"Li, N. et al. Clinical study of pharyngeal swab culture intervention in the treatment of radioactive oral mucositis induced by intensity-modulated radiotherapy for nasopharyngeal carcinoma. Chin J Clin. Ration. Drug. Use. 13, 29\u201332 (2020)."},{"key":"382_CR70","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.ijrobp.2016.08.047","volume":"96","author":"P Bossi","year":"2016","unstructured":"Bossi, P. et al. Salivary Cytokine Levels and Oral Mucositis in Head and Neck Cancer Patients Treated With Chemotherapy and Radiation Therapy. Int. J. Radiat. Oncol. Biol. Phys. 96, 959\u2013966 (2016).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"382_CR71","first-page":"96","volume":"33","author":"E Kauark-Fontes","year":"2025","unstructured":"Kauark-Fontes, E. et al. Machine learning prediction model for oral mucositis risk in head and neck radiotherapy: a preliminary study. Support Care Cancer J. Multinatl. Assoc. Support Care Cancer 33, 96 (2025).","journal-title":"Support Care Cancer J. Multinatl. Assoc. Support Care Cancer"},{"key":"382_CR72","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.radonc.2016.05.015","volume":"120","author":"JA Dean","year":"2016","unstructured":"Dean, J. A. et al. Normal tissue complication probability (NTCP) modelling using spatial dose metrics and machine learning methods for severe acute oral mucositis resulting from head and neck radiotherapy. Radiother. Oncol. J. Eur. Soc. Ther. Radiol. Oncol. 120, 21\u201327 (2016).","journal-title":"Radiother. Oncol. J. Eur. Soc. Ther. Radiol. Oncol."},{"key":"382_CR73","doi-asserted-by":"publisher","first-page":"104563","DOI":"10.1016\/j.ijmedinf.2021.104563","volume":"154","author":"PS Satheeshkumar","year":"2021","unstructured":"Satheeshkumar, P. S., El-Dallal, M. & Mohan, M. P. Feature selection and predicting chemotherapy-induced ulcerative mucositis using machine learning methods. Int. J. Med. Inf. 154, 104563 (2021).","journal-title":"Int. J. Med. Inf."},{"key":"382_CR74","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1080\/17474086.2022.2042248","volume":"15","author":"M Taheriyan","year":"2022","unstructured":"Taheriyan, M., Safaee Nodehi, S., Niakan Kalhori, S. R. & Mohammadzadeh, N. A systematic review of the predicted outcomes related to hematopoietic stem cell transplantation: focus on applied machine learning methods\u2019 performance. Expert Rev. Hematol. 15, 137\u2013156 (2022).","journal-title":"Expert Rev. Hematol."},{"key":"382_CR75","first-page":"773","volume":"24","author":"L Leppla","year":"2016","unstructured":"Leppla, L., De Geest, S., Fierz, K., Deschler-Baier, B. & Koller, A. An oral care self-management support protocol (OrCaSS) to reduce oral mucositis in hospitalized patients with acute myeloid leukemia and allogeneic hematopoietic stem cell transplantation: a randomized controlled pilot study. Support. Care Cancer 24, 773\u2013782 (2016).","journal-title":"Support. Care Cancer"},{"key":"382_CR76","first-page":"7877","volume":"29","author":"PMM Bezerra","year":"2021","unstructured":"Bezerra, P. M. M. et al. The effectiveness of an oral health education and prevention program on the incidence and severity of oral mucositis in pediatric cancer patients: a non-randomized controlled study. Support. Care Cancer 29, 7877\u20137885 (2021).","journal-title":"Support. Care Cancer"},{"key":"382_CR77","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s13187-017-1262-z","volume":"34","author":"U\u00d6 Y\u00fcce","year":"2019","unstructured":"Y\u00fcce, U. \u00d6 & Yurtsever, S. Effect of Education About Oral Mucositis Given to the Cancer Patients Having Chemotherapy on Life Quality. J. Cancer Educ. 34, 35\u201340 (2019).","journal-title":"J. Cancer Educ."},{"key":"382_CR78","doi-asserted-by":"crossref","unstructured":"On behalf of the Mucositis Study Group of the Multinational Association of Supportive Care in Cancer\/International Society for Oral Oncology (MASCC\/ISOO) et al. Systematic review of basic oral care for the management of oral mucositis in cancer patients and clinical practice guidelines. Support. Care Cancer 27, 3949\u20133967 (2019).","DOI":"10.1007\/s00520-019-04848-4"},{"key":"382_CR79","doi-asserted-by":"publisher","first-page":"E118","DOI":"10.1188\/14.CJON.E118-E125","volume":"18","author":"PT Kartin","year":"2014","unstructured":"Kartin, P. T., Tasci, S., Soyuer, S. & Elmali, F. Effect of an Oral Mucositis Protocol on Quality of Life of Patients With Head and Neck Cancer Treated With Radiation Therapy. Clin. J. Oncol. Nurs. 18, E118\u2013E125 (2014).","journal-title":"Clin. J. Oncol. Nurs."},{"key":"382_CR80","first-page":"2133","volume":"22","author":"KG Legert","year":"2014","unstructured":"Legert, K. G., Remberger, M., Ringd\u00e9n, O., Heimdahl, A. & Dahll\u00f6f, G. Reduced intensity conditioning and oral care measures prevent oral mucositis and reduces days of hospitalization in allogeneic stem cell transplantation recipients. Support. Care Cancer 22, 2133\u20132140 (2014).","journal-title":"Support. Care Cancer"},{"key":"382_CR81","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/S0964-1955(96)00053-X","volume":"33","author":"SH Shieh","year":"1997","unstructured":"Shieh, S. H., Wang, S. T., Tsai, S. T. & Tseng, C. C. Mouth care for nasopharyngeal cancer patients undergoing radiotherapy. Oral. Oncol. 33, 36\u201341 (1997).","journal-title":"Oral. Oncol."},{"key":"382_CR82","first-page":"13","volume":"23","author":"J Bos-den Braber","year":"2015","unstructured":"Bos-den Braber, J., Potting, C. M. J., Bronkhorst, E. M., Huysmans, M.-C. D. N. J. M. & Blijlevens, N. M. A. Oral complaints and dental care of haematopoietic stem cell transplant patients: a qualitative survey of patients and their dentists. Support. Care Cancer 23, 13\u201319 (2015).","journal-title":"Support. Care Cancer"},{"key":"382_CR83","first-page":"2935","volume":"22","author":"H Saito","year":"2014","unstructured":"Saito, H. et al. Effects of professional oral health care on reducing the risk of chemotherapy-induced oral mucositis. Support. Care Cancer 22, 2935\u20132940 (2014).","journal-title":"Support. Care Cancer"},{"key":"382_CR84","doi-asserted-by":"publisher","first-page":"e223","DOI":"10.1634\/theoncologist.2019-0382","volume":"25","author":"N Niikura","year":"2020","unstructured":"Niikura, N. et al. Oral Care Evaluation to Prevent Oral Mucositis in Estrogen Receptor-Positive Metastatic Breast Cancer Patients Treated with Everolimus (Oral Care-BC): A Randomized Controlled Phase III Trial. Oncologist 25, e223\u2013e230 (2020).","journal-title":"Oncologist"},{"key":"382_CR85","first-page":"223","volume":"23","author":"S Elad","year":"2015","unstructured":"Elad, S. et al. Basic oral care for hematology\u2013oncology patients and hematopoietic stem cell transplantation recipients: a position paper from the joint task force of the Multinational Association of Supportive Care in Cancer\/International Society of Oral Oncology (MASCC\/ISOO) and the European Society for Blood and Marrow Transplantation (EBMT). Support. Care Cancer 23, 223\u2013236 (2015).","journal-title":"Support. Care Cancer"},{"key":"382_CR86","unstructured":"Cheng, B., Li, C. & Xia, J. Diagnosis and Treatment of Radiotherapy-Induced Oral Mucositis. Chin. J. Pract. Stomatol. 1, 513\u2013516 (2008)."},{"key":"382_CR87","doi-asserted-by":"publisher","first-page":"e19661","DOI":"10.1097\/MD.0000000000019661","volume":"99","author":"Y Yu","year":"2020","unstructured":"Yu, Y. et al. Effects of 9 oral care solutions on the prevention of oral mucositis: a network meta-analysis of randomized controlled trials. Med. (Baltim.) 99, e19661 (2020).","journal-title":"Med. (Baltim.)"},{"key":"382_CR88","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1111\/jop.12549","volume":"46","author":"A Cardona","year":"2017","unstructured":"Cardona, A., Balouch, A., Abdul, M. M., Sedghizadeh, P. P. & Enciso, R. Efficacy of chlorhexidine for the prevention and treatment of oral mucositis in cancer patients: a systematic review with meta-analyses. J. Oral. Pathol. Med. 46, 680\u2013688 (2017).","journal-title":"J. Oral. Pathol. Med."},{"key":"382_CR89","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/0030-4220(90)90295-4","volume":"69","author":"GA Ferretti","year":"1990","unstructured":"Ferretti, G. A. et al. Chlorhexidine prophylaxis for chemotherapy-and radiotherapy-induced stomatitis: A randomized double-blind trial. Oral. Surg. Oral. Med. Oral. Pathol. 69, 331\u2013338 (1990).","journal-title":"Oral. Surg. Oral. Med. Oral. Pathol."},{"key":"382_CR90","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4103\/0973-1482.39597","volume":"4","author":"P Madan Kumar","year":"2008","unstructured":"Madan Kumar, P., Sequeira, P., Shenoy, K. & Shetty, J. The effect of three mouthwashes on radiation-induced oral mucositis in patients with head and neck malignancies: A randomized control trial. J. Cancer Res. Ther. 4, 3 (2008).","journal-title":"J. Cancer Res. Ther."},{"key":"382_CR91","doi-asserted-by":"publisher","first-page":"2630","DOI":"10.1200\/JCO.1994.12.12.2630","volume":"12","author":"RL Foote","year":"1994","unstructured":"Foote, R. L. et al. Randomized trial of a chlorhexidine mouthwash for alleviation of radiation-induced mucositis. J. Clin. Oncol. 12, 2630\u20132633 (1994).","journal-title":"J. Clin. Oncol."},{"key":"382_CR92","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.anr.2012.05.004","volume":"6","author":"S-E Choi","year":"2012","unstructured":"Choi, S.-E. & Kim, H.-S. Sodium Bicarbonate Solution versus Chlorhexidine Mouthwash in Oral Care of Acute Leukemia Patients Undergoing Induction Chemotherapy: A Randomized Controlled Trial. Asian Nurs. Res. 6, 60\u201366 (2012).","journal-title":"Asian Nurs. Res."},{"key":"382_CR93","first-page":"879","volume":"26","author":"I Chitapanarux","year":"2018","unstructured":"Chitapanarux, I. et al. Randomized control trial of benzydamine HCl versus sodium bicarbonate for prophylaxis of concurrent chemoradiation-induced oral mucositis. Support. Care Cancer 26, 879\u2013886 (2018).","journal-title":"Support. Care Cancer"},{"key":"382_CR94","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1111\/1523-1747.ep12396936","volume":"103","author":"S Braunstein","year":"1994","unstructured":"Braunstein, S. et al. GM-CSF Activates Regenerative Epidermal Growth and Stimulates Keratinocyte Proliferation in Human Skin In Vivo. J. Invest. Dermatol. 103, 601\u2013604 (1994).","journal-title":"J. Invest. Dermatol."},{"key":"382_CR95","unstructured":"Yu, M., Yang, Z., Chen, F., Zhou, P. & Zhao, Y. Effect of granulocyte-macrophage colony-stimulating factor gargle and deglutition to prevent oral mucositis in patients after conditioning of hematopoietic stem cell transplantation. Chin J Inj. Repair Wound Heal. Electron. Ed. 13, 215\u2013219 (2018)."},{"key":"382_CR96","unstructured":"Lin, F. & Xu, L. Clinical effect of Gm-CSF gargling on acute radiation oral mucositis of nasopharyngeal carcinoma. Chin. J. Clin. Ration. Drug. Use. 11, 77\u201378 (2018)."},{"key":"382_CR97","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/S0360-3016(02)02935-8","volume":"54","author":"K Saarilahti","year":"2002","unstructured":"Saarilahti, K., Kajanti, M., Joensuu, T., Kouri, M. & Joensuu, H. Comparison of granulocyte-macrophage colony-stimulating factor and sucralfate mouthwashes in the prevention of radiation-induced mucositis: a double-blind prospective randomized phase III study. Int. J. Radiat. Oncol. 54, 479\u2013485 (2002).","journal-title":"Int. J. Radiat. Oncol."},{"key":"382_CR98","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/S0360-3016(99)00452-6","volume":"46","author":"TA Makkonen","year":"2000","unstructured":"Makkonen, T. A. et al. Granulocyte macrophage-colony stimulating factor (GM-CSF) and sucralfate in prevention of radiation-induced mucositis: a prospective randomized study. Int. J. Radiat. Oncol. 46, 525\u2013534 (2000).","journal-title":"Int. J. Radiat. Oncol."},{"key":"382_CR99","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.ijrobp.2006.09.043","volume":"67","author":"JK Ryu","year":"2007","unstructured":"Ryu, J. K. et al. The impact of concurrent granulocyte macrophage-colony stimulating factor on radiation-induced mucositis in head and neck cancer patients: A double-blind placebo-controlled prospective Phase III study by Radiation Therapy Oncology Group 9901. Int. J. Radiat. Oncol. 67, 643\u2013650 (2007).","journal-title":"Int. J. Radiat. Oncol."},{"key":"382_CR100","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1007\/s11136-014-0628-5","volume":"23","author":"KE Hoffman","year":"2014","unstructured":"Hoffman, K. E. et al. The impact of concurrent granulocyte\u2013macrophage colony-stimulating factor on quality of life in head and neck cancer patients: results of the randomized, placebo-controlled Radiation Therapy Oncology Group 9901 trial. Qual. Life Res. 23, 1841\u20131858 (2014).","journal-title":"Qual. Life Res."},{"key":"382_CR101","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1385\/MO:22:3:257","volume":"22","author":"JA Sparano","year":"2005","unstructured":"Sparano, J. A. et al. Phase I Trial of Infusional Cyclophosphamide, Doxorubicin, and Etoposide plus Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) in Non-Hodgkin\u2019s Lymphoma. Med. Oncol. 22, 257\u2013268 (2005).","journal-title":"Med. Oncol."},{"key":"382_CR102","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1259\/bjr\/55190439","volume":"79","author":"JJ McAleese","year":"2006","unstructured":"McAleese, J. J., Bishop, K. M., A\u2019Hern, R. & Henk, J. M. Randomized phase II study of GM-CSF to reduce mucositis caused by accelerated radiotherapy of laryngeal cancer. Br. J. Radiol. 79, 608\u2013613 (2006).","journal-title":"Br. J. Radiol."},{"key":"382_CR103","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1007\/BF02912445","volume":"27","author":"M Sironi","year":"1997","unstructured":"Sironi, M. et al. Benzydamine inhibits the release of tumor necrosis factor-alpha and monocyte chemotactic protein-1 by Candida albicans-stimulated human peripheral blood cells. Int. J. Clin. Lab. Res. 27, 118\u2013122 (1997).","journal-title":"Int. J. Clin. Lab. Res."},{"key":"382_CR104","first-page":"99","volume":"9","author":"MM Schubert","year":"1987","unstructured":"Schubert, M. M. & Newton, R. E. The use of benzydamine HCl for the management of cancer therapy-induced mucositis: preliminary report of a multicentre study. Int. J. Tissue React. 9, 99\u2013103 (1987).","journal-title":"Int. J. Tissue React."},{"key":"382_CR105","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1002\/1097-0142(20010815)92:4<875::AID-CNCR1396>3.0.CO;2-1","volume":"92","author":"JB Epstein","year":"2001","unstructured":"Epstein, J. B. et al. Benzydamine HCl for prophylaxis of radiation-induced oral mucositis: Results from a multicenter, randomized, double-blind, placebo-controlled clinical trial. Cancer 92, 875\u2013885 (2001).","journal-title":"Cancer"},{"key":"382_CR106","first-page":"1439","volume":"25","author":"M Rastogi","year":"2017","unstructured":"Rastogi, M. et al. Role of benzydamine hydrochloride in the prevention of oral mucositis in head and neck cancer patients treated with radiotherapy (>50 Gy) with or without chemotherapy. Support. Care Cancer 25, 1439\u20131443 (2017).","journal-title":"Support. Care Cancer"},{"key":"382_CR107","doi-asserted-by":"publisher","first-page":"104751","DOI":"10.1016\/j.oraloncology.2020.104751","volume":"107","author":"X Zhang","year":"2020","unstructured":"Zhang, X. et al. Comparative prevention potential of 10 mouthwashes on intolerable oral mucositis in cancer patients: A Bayesian network analysis. Oral. Oncol. 107, 104751 (2020).","journal-title":"Oral. Oncol."},{"key":"382_CR108","unstructured":"Yu, Y. et al. Efficacy of nine mouthwashes for the prevention of oral mucositis in cancer patients: a network Meta-analysis. Chin. Nurs. Manag. 19, 350\u2013358 (2019)."},{"key":"382_CR109","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/0014-2999(92)90065-C","volume":"212","author":"K Ogino","year":"1992","unstructured":"Ogino, K. et al. Antiulcer mechanism of action of rebamipide, a novel antiulcer compound, on diethyldithiocarbamate-induced antral gastric ulcers in rats. Eur. J. Pharmacol. 212, 9\u201313 (1992).","journal-title":"Eur. J. Pharmacol."},{"key":"382_CR110","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/0891-5849(94)00110-6","volume":"18","author":"Y Naito","year":"1995","unstructured":"Naito, Y. et al. Hydroxyl radical scavenging by rebamipide and related compounds: Electron paramagnetic resonance study. Free Radic. Biol. Med. 18, 117\u2013123 (1995).","journal-title":"Free Radic. Biol. Med."},{"key":"382_CR111","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.oraloncology.2017.07.024","volume":"72","author":"B Chaitanya","year":"2017","unstructured":"Chaitanya, B., Pai, K. M., Yathiraj, P. H., Fernandes, D. & Chhaparwal, Y. Rebamipide gargle in preventive management of chemo-radiotherapy induced oral mucositis. Oral. Oncol. 72, 179\u2013182 (2017).","journal-title":"Oral. Oncol."},{"key":"382_CR112","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-017-3295-4","volume":"17","author":"T Yokota","year":"2017","unstructured":"Yokota, T. et al. Efficacy and safety of rebamipide liquid for chemoradiotherapy-induced oral mucositis in patients with head and neck cancer: a multicenter, randomized, double-blind, placebo-controlled, parallel-group phase II study. BMC Cancer 17, 314 (2017).","journal-title":"BMC Cancer"},{"key":"382_CR113","doi-asserted-by":"publisher","first-page":"2808","DOI":"10.1200\/JCO.2010.32.4095","volume":"29","author":"Q-T Le","year":"2011","unstructured":"Le, Q.-T. et al. Palifermin Reduces Severe Mucositis in Definitive Chemoradiotherapy of Locally Advanced Head and Neck Cancer: A Randomized, Placebo-Controlled Study. J. Clin. Oncol. 29, 2808\u20132814 (2011).","journal-title":"J. Clin. Oncol."},{"key":"382_CR114","doi-asserted-by":"publisher","first-page":"2815","DOI":"10.1200\/JCO.2010.32.4103","volume":"29","author":"M Henke","year":"2011","unstructured":"Henke, M. et al. Palifermin Decreases Severe Oral Mucositis of Patients Undergoing Postoperative Radiochemotherapy for Head and Neck Cancer: A Randomized, Placebo-Controlled Trial. J. Clin. Oncol. 29, 2815\u20132820 (2011).","journal-title":"J. Clin. Oncol."},{"key":"382_CR115","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1111\/bjh.13086","volume":"167","author":"KF Bradstock","year":"2014","unstructured":"Bradstock, K. F. et al. A randomized trial of prophylactic palifermin on gastrointestinal toxicity after intensive induction therapy for acute myeloid leukaemia. Br. J. Haematol. 167, 618\u2013625 (2014).","journal-title":"Br. J. Haematol."},{"key":"382_CR116","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/S0899-9007(98)00009-4","volume":"14","author":"DW Wilmore","year":"1998","unstructured":"Wilmore, D. W. & Shabert, J. K. Role of glutamine in immunologic responses. Nutrition 14, 618\u2013626 (1998).","journal-title":"Nutrition"},{"key":"382_CR117","doi-asserted-by":"publisher","first-page":"3199","DOI":"10.1002\/hed.26798","volume":"43","author":"HM Alsubaie","year":"2021","unstructured":"Alsubaie, H. M. et al. Glutamine for prevention and alleviation of radiation-induced oral mucositis in patients with head and neck squamous cell cancer: Systematic review and meta-analysis of controlled trials. Head. Neck 43, 3199\u20133213 (2021).","journal-title":"Head. Neck"},{"key":"382_CR118","doi-asserted-by":"publisher","first-page":"008","DOI":"10.4103\/2278-330X.126501","volume":"03","author":"S Chattopadhyay","year":"2014","unstructured":"Chattopadhyay, S., Saha, A., Azam, M., Mukherjee, A. & Sur, P. K. Role of oral glutamine in alleviation and prevention of radiation-induced oral mucositis: A prospective randomized study. South Asian J. Cancer 03, 008\u2013012 (2014).","journal-title":"South Asian J. Cancer"},{"key":"382_CR119","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1002\/cncr.22384","volume":"109","author":"DE Peterson","year":"2007","unstructured":"Peterson, D. E., Jones, J. B. & Petit, R. G. Randomized, placebo-controlled trial of Saforis for prevention and treatment of oral mucositis in breast cancer patients receiving anthracycline-based chemotherapy. Cancer 109, 322\u2013331 (2007).","journal-title":"Cancer"},{"key":"382_CR120","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1002\/(SICI)1097-0142(19981001)83:7<1433::AID-CNCR22>3.0.CO;2-4","volume":"83","author":"PM Anderson","year":"1998","unstructured":"Anderson, P. M., Schroeder, G. & Skubitz, K. M. Oral glutamine reduces the duration and severity of stomatitis after cytotoxic cancer chemotherapy. Cancer 83, 1433\u20131439 (1998).","journal-title":"Cancer"},{"key":"382_CR121","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/j.jds.2021.01.009","volume":"16","author":"S Soutome","year":"2021","unstructured":"Soutome, S. et al. Risk factors for severe radiation-induced oral mucositis in patients with oral cancer. J. Dent. Sci. 16, 1241\u20131246 (2021).","journal-title":"J. Dent. Sci."},{"key":"382_CR122","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1016\/S0959-8049(01)00189-7","volume":"37","author":"A Awidi","year":"2001","unstructured":"Awidi, A. et al. Double-blind, placebo-controlled cross-over study of oral pilocarpine for the prevention of chemotherapy-induced oral mucositis in adult patients with cancer. Eur. J. Cancer 37, 2010\u20132014 (2001).","journal-title":"Eur. J. Cancer"},{"key":"382_CR123","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/sj.bmt.1704820","volume":"35","author":"PB Lockhart","year":"2005","unstructured":"Lockhart, P. B. et al. Randomized controlled trial of pilocarpine hydrochloride for the moderation of oral mucositis during autologous blood stem cell transplantation. Bone Marrow Transpl. 35, 713\u2013720 (2005).","journal-title":"Bone Marrow Transpl."},{"key":"382_CR124","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1007\/s10439-011-0454-7","volume":"40","author":"H Chung","year":"2012","unstructured":"Chung, H. et al. The Nuts and Bolts of Low-level Laser (Light) Therapy. Ann. Biomed. Eng. 40, 516\u2013533 (2012).","journal-title":"Ann. Biomed. Eng."},{"key":"382_CR125","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1007\/s10103-020-03060-9","volume":"35","author":"LFM Nunes","year":"2020","unstructured":"Nunes, L. F. M. et al. Prophylactic photobiomodulation therapy using 660 nm diode laser for oral mucositis in paediatric patients under chemotherapy: 5-year experience from a Brazilian referral service. Lasers Med. Sci. 35, 1857\u20131866 (2020).","journal-title":"Lasers Med. Sci."},{"key":"382_CR126","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.ejca.2021.05.013","volume":"154","author":"P Patel","year":"2021","unstructured":"Patel, P. et al. Clinical practice guideline for the prevention of oral and oropharyngeal mucositis in pediatric cancer and hematopoietic stem cell transplant patients: 2021 update. Eur. J. Cancer 154, 92\u2013101 (2021).","journal-title":"Eur. J. Cancer"},{"key":"382_CR127","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s00431-017-3043-4","volume":"177","author":"M He","year":"2018","unstructured":"He, M., Zhang, B., Shen, N., Wu, N. & Sun, J. A systematic review and meta-analysis of the effect of low-level laser therapy (LLLT) on chemotherapy-induced oral mucositis in pediatric and young patients. Eur. J. Pediatr. 177, 7\u201317 (2018).","journal-title":"Eur. J. Pediatr."},{"key":"382_CR128","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.oooo.2020.05.014","volume":"130","author":"J Peng","year":"2020","unstructured":"Peng, J. et al. Low-level laser therapy in the prevention and treatment of oral mucositis: a systematic review and meta-analysis. Oral. Surg. Oral. Med. Oral. Pathol. Oral. Radiol. 130, 387\u2013397.e9 (2020).","journal-title":"Oral. Surg. Oral. Med. Oral. Pathol. Oral. Radiol."},{"key":"382_CR129","doi-asserted-by":"publisher","first-page":"104524","DOI":"10.1016\/j.oraloncology.2019.104524","volume":"102","author":"VHS De Lima","year":"2020","unstructured":"De Lima, V. H. S., De Oliveira-Neto, O. B., Da Hora Sales, P. H., Da Silva Torres, T. & De Lima, F. J. C. Effectiveness of low-level laser therapy for oral mucositis prevention in patients undergoing chemoradiotherapy for the treatment of head and neck cancer: A systematic review and meta-analysis. Oral. Oncol. 102, 104524 (2020).","journal-title":"Oral. Oncol."},{"key":"382_CR130","first-page":"364","volume":"40","author":"JB Dantas","year":"2020","unstructured":"Dantas, J. B. et al. Evaluation of preventive laser photobiomodulation in patients with head and neck cancer undergoing radiochemotherapy: Laser in patients with head and neck cancer. Spec. Care Dent. Publ. Am. Assoc. Hosp. Dent. Acad. Dent. Handicap. Am. Soc. Geriatr. Dent. 40, 364\u2013373 (2020).","journal-title":"Spec. Care Dent. Publ. Am. Assoc. Hosp. Dent. Acad. Dent. Handicap. Am. Soc. Geriatr. Dent."},{"key":"382_CR131","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1002\/jbio.201300015","volume":"6","author":"FF Sperandio","year":"2013","unstructured":"Sperandio, F. F. et al. Low-level laser therapy can produce increased aggressiveness of dysplastic and oral cancer cell lines by modulation of Akt\/mTOR signaling pathway. J. Biophotonics 6, 839\u2013847 (2013).","journal-title":"J. Biophotonics"},{"key":"382_CR132","doi-asserted-by":"publisher","unstructured":"Gomes Henriques, \u00c1. C. et al. Low-level laser therapy promotes proliferation and invasion of oral squamous cell carcinoma cells. Lasers Med. Sci. https:\/\/doi.org\/10.1007\/s10103-014-1535-2 (2014).","DOI":"10.1007\/s10103-014-1535-2"},{"key":"382_CR133","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-9-404","volume":"9","author":"L Frigo","year":"2009","unstructured":"Frigo, L. et al. The effect of low-level laser irradiation (In-Ga-Al-AsP - 660 nm) on melanoma in vitro and in vivo. BMC Cancer 9, 404 (2009).","journal-title":"BMC Cancer"},{"key":"382_CR134","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.oraloncology.2017.05.018","volume":"71","author":"HS Antunes","year":"2017","unstructured":"Antunes, H. S. et al. Long-term survival of a randomized phase III trial of head and neck cancer patients receiving concurrent chemoradiation therapy with or without low-level laser therapy (LLLT) to prevent oral mucositis. Oral. Oncol. 71, 11\u201315 (2017).","journal-title":"Oral. Oncol."},{"key":"382_CR135","first-page":"2417","volume":"26","author":"TB Brand\u00e3o","year":"2018","unstructured":"Brand\u00e3o, T. B. et al. Locally advanced oral squamous cell carcinoma patients treated with photobiomodulation for prevention of oral mucositis: retrospective outcomes and safety analyses. Support. Care Cancer 26, 2417\u20132423 (2018).","journal-title":"Support. Care Cancer"},{"key":"382_CR136","doi-asserted-by":"publisher","first-page":"103276","DOI":"10.1016\/j.critrevonc.2021.103276","volume":"160","author":"C-C Lai","year":"2021","unstructured":"Lai, C.-C., Chen, S.-Y., Tu, Y.-K., Ding, Y.-W. & Lin, J.-J. Effectiveness of low level laser therapy versus cryotherapy in cancer patients with oral mucositis: Systematic review and network meta-analysis. Crit. Rev. Oncol. Hematol. 160, 103276 (2021).","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"382_CR137","first-page":"4263","volume":"28","author":"MO Morais","year":"2020","unstructured":"Morais, M. O. et al. A prospective study on oral adverse effects in head and neck cancer patients submitted to a preventive oral care protocol. Support. Care Cancer J. Multinatl. Assoc. Support. Care Cancer 28, 4263\u20134273 (2020).","journal-title":"Support. Care Cancer J. Multinatl. Assoc. Support. Care Cancer"},{"key":"382_CR138","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.oraloncology.2017.11.001","volume":"75","author":"H Peng","year":"2017","unstructured":"Peng, H. et al. A network meta-analysis in comparing prophylactic treatments of radiotherapy-induced oral mucositis for patients with head and neck cancers receiving radiotherapy. Oral. Oncol. 75, 89\u201394 (2017).","journal-title":"Oral. Oncol."},{"key":"382_CR139","first-page":"554","volume":"13","author":"S Vokurka","year":"2005","unstructured":"Vokurka, S. et al. The comparative effects of povidone-iodine and normal saline mouthwashes on oral mucositis in patients after high-dose chemotherapy and APBSCT\u2014results of a randomized multicentre study. Support. Care Cancer 13, 554\u2013558 (2005).","journal-title":"Support. Care Cancer"},{"key":"382_CR140","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/S1368-8375(99)00075-5","volume":"36","author":"D Etiz","year":"2000","unstructured":"Etiz, D. et al. Clinical and histopathological evaluation of sucralfate in prevention of oral mucositis induced by radiation therapy in patients with head and neck malignancies. Oral. Oncol. 36, 116\u2013120 (2000).","journal-title":"Oral. Oncol."},{"key":"382_CR141","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1023\/A:1011119721267","volume":"12","author":"L Castagna","year":"2001","unstructured":"Castagna, L. et al. Prevention of mucositis in bone marrow transplantation: A double blind randomised controlled trial of sucralfate. Ann. Oncol. 12, 953\u2013955 (2001).","journal-title":"Ann. Oncol."},{"key":"382_CR142","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1080\/01635581.2016.1153666","volume":"68","author":"S Ala","year":"2016","unstructured":"Ala, S. et al. Efficacy of Sucralfate Mouth Wash in Prevention of 5-fluorouracil Induced Oral Mucositis: A Prospective, Randomized, Double-Blind, Controlled Trial. Nutr. Cancer 68, 456\u2013463 (2016).","journal-title":"Nutr. Cancer"},{"key":"382_CR143","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1136\/ejhpharm-2018-001649","volume":"27","author":"P Wilairat","year":"2020","unstructured":"Wilairat, P. et al. Comparative efficacy and safety of interventions for preventing chemotherapy-induced oral mucositis in adult cancer patients: a systematic review and network meta-analysis. Eur. J. Hosp. Pharm. 27, 103\u2013110 (2020).","journal-title":"Eur. J. Hosp. Pharm."},{"key":"382_CR144","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1002\/(SICI)1097-0347(199912)21:8<760::AID-HED12>3.0.CO;2-#","volume":"21","author":"DL Carter","year":"1999","unstructured":"Carter, D. L. et al. Double blind randomized trial of sucralfate vs placebo during radical radiotherapy for head and neck cancers. Head. Neck 21, 760\u2013766 (1999).","journal-title":"Head. Neck"},{"key":"382_CR145","first-page":"41","volume":"11","author":"M Nottage","year":"2003","unstructured":"Nottage, M. et al. Sucralfate mouthwash for prevention and treatment of 5-fluorouracil-induced mucositis: a randomized, placebo-controlled trial. Support. Care Cancer 11, 41\u201347 (2003).","journal-title":"Support. Care Cancer"},{"key":"382_CR146","doi-asserted-by":"publisher","first-page":"2852","DOI":"10.3390\/curroncol28040250","volume":"28","author":"AHM Al-Rudayni","year":"2021","unstructured":"Al-Rudayni, A. H. M., Gopinath, D., Maharajan, M. K., Veettil, S. K. & Menon, R. K. Efficacy of Oral Cryotherapy in the Prevention of Oral Mucositis Associated with Cancer Chemotherapy: Systematic Review with Meta-Analysis and Trial Sequential Analysis. Curr. Oncol. 28, 2852\u20132867 (2021).","journal-title":"Curr. Oncol."},{"key":"382_CR147","doi-asserted-by":"publisher","first-page":"e12759","DOI":"10.1111\/ijn.12759","volume":"25","author":"S Park","year":"2019","unstructured":"Park, S. & Lee, H. S. Meta-analysis of oral cryotherapy in preventing oral mucositis associated with cancer therapy. Int. J. Nurs. Pract. 25, e12759 (2019).","journal-title":"Int. J. Nurs. Pract."},{"key":"382_CR148","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1136\/bmjspcare-2014-000804","volume":"7","author":"L Sung","year":"2017","unstructured":"Sung, L. et al. Guideline for the prevention of oral and oropharyngeal mucositis in children receiving treatment for cancer or undergoing haematopoietic stem cell transplantation. BMJ Support. Palliat. Care 7, 7\u201316 (2017).","journal-title":"BMJ Support. Palliat. Care"},{"key":"382_CR149","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1111\/j.1365-2702.2010.03255.x","volume":"19","author":"A Svanberg","year":"2010","unstructured":"Svanberg, A., \u00d6hrn, K. & Birgeg\u00e5rd, G. Oral cryotherapy reduces mucositis and improves nutrition \u2013 a randomised controlled trial. J. Clin. Nurs. 19, 2146\u20132151 (2010).","journal-title":"J. Clin. Nurs."},{"key":"382_CR150","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1002\/cncr.23328","volume":"112","author":"JB Sorensen","year":"2008","unstructured":"Sorensen, J. B., Skovsgaard, T., Bork, E., Damstrup, L. & Ingeberg, S. Double-blind, placebo-controlled, randomized study of chlorhexidine prophylaxis for 5-fluorouracil-based chemotherapy-induced oral mucositis with nonblinded randomized comparison to oral cooling (cryotherapy) in gastrointestinal malignancies. Cancer 112, 1600\u20131606 (2008).","journal-title":"Cancer"},{"key":"382_CR151","doi-asserted-by":"publisher","first-page":"4010","DOI":"10.1002\/hed.26848","volume":"43","author":"A Singh","year":"2021","unstructured":"Singh, A. et al. Intraoral radiation stents-Primer for clinical use in head and neck cancer therapy. Head. Neck 43, 4010\u20134017 (2021).","journal-title":"Head. Neck"},{"key":"382_CR152","doi-asserted-by":"publisher","first-page":"23","DOI":"10.7883\/yoken.JJID.2007.23","volume":"60","author":"S Yoneda","year":"2007","unstructured":"Yoneda, S. et al. Effects of oral care on development of oral mucositis and microorganisms in patients with esophageal cancer. Jpn. J. Infect. Dis. 60, 23\u201328 (2007).","journal-title":"Jpn. J. Infect. Dis."},{"key":"382_CR153","first-page":"137","volume":"14","author":"M Djuric","year":"2006","unstructured":"Djuric, M., Hillier-Kolarov, V., Belic, A. & Jankovic, L. Mucositis prevention by improved dental care in acute leukemia patients. Support. Care Cancer 14, 137\u2013146 (2006).","journal-title":"Support. Care Cancer"},{"key":"382_CR154","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.1007\/s00431-021-04024-z","volume":"180","author":"ILA Ribeiro","year":"2021","unstructured":"Ribeiro, I. L. A. et al. Integrated oral care contributes positively to the course of treatment of oncopediatric patients. Eur. J. Pediatr. 180, 2757\u20132764 (2021).","journal-title":"Eur. J. Pediatr."},{"key":"382_CR155","first-page":"326","volume":"6","author":"T Rojas de Morales","year":"2001","unstructured":"Rojas de Morales, T. et al. Oral-disease prevention in children with cancer: testing preventive protocol effectiveness. Med. Oral. Organo. Soc. Espanola Med. Oral. Acad. Iberoam. Patol. Med. Bucal 6, 326\u2013334 (2001).","journal-title":"Med. Oral. Organo. Soc. Espanola Med. Oral. Acad. Iberoam. Patol. Med. Bucal"},{"key":"382_CR156","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0304-3959(02)00375-5","volume":"103","author":"Y Sudoh","year":"2003","unstructured":"Sudoh, Y., Cahoon, E. E., Gerner, P. & Wang, G. K. Tricyclic antidepressants as long-acting local anesthetics. Pain 103, 49\u201355 (2003).","journal-title":"Pain"},{"key":"382_CR157","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1001\/jama.2019.3504","volume":"321","author":"TT Sio","year":"2019","unstructured":"Sio, T. T. et al. Effect of Doxepin Mouthwash or Diphenhydramine-Lidocaine-Antacid Mouthwash vs Placebo on Radiotherapy-Related Oral Mucositis Pain: The Alliance A221304 Randomized Clinical Trial. JAMA 321, 1481 (2019).","journal-title":"JAMA"},{"key":"382_CR158","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1200\/JCO.2013.53.2630","volume":"32","author":"JL Leenstra","year":"2014","unstructured":"Leenstra, J. L. et al. Doxepin Rinse Versus Placebo in the Treatment of Acute Oral Mucositis Pain in Patients Receiving Head and Neck Radiotherapy With or Without Chemotherapy: A Phase III, Randomized, Double-Blind Trial (NCCTG-N09C6 [Alliance]). J. Clin. Oncol. 32, 1571\u20131577 (2014).","journal-title":"J. Clin. Oncol."},{"key":"382_CR159","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/j.1754-4505.2008.00015.x","volume":"28","author":"JB Epstein","year":"2008","unstructured":"Epstein, J. B., Epstein, J. D., Epstein, M. S., Oien, H. & Truelove, E. L. Doxepin rinse for management of mucositis pain in patients with cancer: one week follow-up of topical therapy. Spec. Care Dent. 28, 73\u201377 (2008).","journal-title":"Spec. Care Dent."},{"key":"382_CR160","doi-asserted-by":"crossref","unstructured":"Epstein, J. B. et al. Oral topical doxepin rinse: analgesic effect in patients with oral mucosal pain due to cancer or cancer therapy. Oral Oncol. (2001).","DOI":"10.1016\/S1368-8375(01)00005-7"},{"key":"382_CR161","first-page":"528","volume":"14","author":"A Barasch","year":"2006","unstructured":"Barasch, A., Elad, S., Altman, A., Damato, K. & Epstein, J. Antimicrobials, mucosal coating agents, anesthetics, analgesics, and nutritional supplements for alimentary tract mucositis. Support. Care Cancer 14, 528\u2013532 (2006).","journal-title":"Support. Care Cancer"},{"key":"382_CR162","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1177\/019459989010200404","volume":"102","author":"SB Carnel","year":"1990","unstructured":"Carnel, S. B., Blakeslee, D. B., Oswald, S. G. & Barnes, M. Treatment of Radiation- and Chemotherapy-Induced Stomatitis. Otolaryngol. Neck Surg. 102, 326\u2013330 (1990).","journal-title":"Otolaryngol. Neck Surg."},{"key":"382_CR163","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.ijrobp.2005.07.301","volume":"64","author":"D Alterio","year":"2006","unstructured":"Alterio, D. et al. Tetracaine oral gel in patients treated with radiotherapy for head-and-neck cancer: Final results of a phase II study. Int. J. Radiat. Oncol. 64, 392\u2013395 (2006).","journal-title":"Int. J. Radiat. Oncol."},{"key":"382_CR164","doi-asserted-by":"publisher","first-page":"614877","DOI":"10.3389\/fonc.2021.614877","volume":"11","author":"F Agha-Hosseini","year":"2021","unstructured":"Agha-Hosseini, F., Pourpasha, M., Amanlou, M. & Moosavi, M.-S. Mouthwash Containing Vitamin E, Triamcinolon, and Hyaluronic Acid Compared to Triamcinolone Mouthwash Alone in Patients With Radiotherapy-Induced Oral Mucositis: Randomized Clinical Trial. Front. Oncol. 11, 614877 (2021).","journal-title":"Front. Oncol."},{"key":"382_CR165","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-021-09107-6","volume":"22","author":"T Ueno","year":"2022","unstructured":"Ueno, T., Yatsuoka, W., Ishiki, H., Miyano, K. & Uezono, Y. Effects of an oral mucosa protective formulation on chemotherapy- and\/or radiotherapy-induced oral mucositis: a prospective study. BMC Cancer 22, 90 (2022).","journal-title":"BMC Cancer"},{"key":"382_CR166","doi-asserted-by":"publisher","first-page":"8555","DOI":"10.2147\/OTT.S185915","volume":"11","author":"Y Cheng","year":"2018","unstructured":"Cheng, Y. et al. Local analgesic effect of a bioadhesive barrier-forming oral liquid in cancer patients with oral mucositis caused by chemotherapy and\/or radiotherapy: a randomized multicenter, single-use, positive-controlled, open-label study. OncoTargets Ther. 11, 8555\u20138564 (2018).","journal-title":"OncoTargets Ther."},{"key":"382_CR167","first-page":"1557","volume":"22","author":"T Hadjieva","year":"2014","unstructured":"Hadjieva, T., Cavallin-St\u00e5hl, E., Linden, M. & Tiberg, F. Treatment of oral mucositis pain following radiation therapy for head-and-neck cancer using a bioadhesive barrier-forming lipid solution. Support. Care Cancer 22, 1557\u20131562 (2014).","journal-title":"Support. Care Cancer"},{"key":"382_CR168","doi-asserted-by":"publisher","first-page":"8","DOI":"10.4103\/0976-237X.79292","volume":"2","author":"G Roopashri","year":"2011","unstructured":"Roopashri, G., Jayanthi, K. & Guruprasad, R. Efficacy of benzydamine hydrochloride, chlorhexidine, and povidone iodine in the treatment of oral mucositis among patients undergoing radiotherapy in head and neck malignancies: A drug trail. Contemp. Clin. Dent. 2, 8 (2011).","journal-title":"Contemp. Clin. Dent."},{"key":"382_CR169","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ejon.2017.11.006","volume":"32","author":"S Cabrera-Jaime","year":"2018","unstructured":"Cabrera-Jaime, S. et al. Efficacy of Plantago major, chlorhexidine 0.12% and sodium bicarbonate 5% solution in the treatment of oral mucositis in cancer patients with solid tumour: A feasibility randomised triple-blind phase III clinical trial. Eur. J. Oncol. Nurs. 32, 40\u201347 (2018).","journal-title":"Eur. J. Oncol. Nurs."},{"key":"382_CR170","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1002\/nop2.1168","volume":"9","author":"F Mohammadi","year":"2022","unstructured":"Mohammadi, F. et al. Effectiveness of sodium bicarbonate and zinc chloride mouthwashes in the treatment of oral mucositis and quality of life in patients with cancer under chemotherapy. Nurs. Open 9, 1602\u20131611 (2022).","journal-title":"Nurs. Open"},{"key":"382_CR171","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1111\/j.1439-0507.2009.01728.x","volume":"53","author":"N Isham","year":"2010","unstructured":"Isham, N. & Ghannoum, M. A. Antifungal activity of miconazole against recent Candida strains: Miconazole antifungal activity vs. Candida. Mycoses 53, 434\u2013437 (2010).","journal-title":"Mycoses"},{"key":"382_CR172","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1093\/cid\/cis205","volume":"54","author":"JA Vazquez","year":"2012","unstructured":"Vazquez, J. A. & Sobel, J. D. Miconazole Mucoadhesive Tablets: A Novel Delivery System. Clin. Infect. Dis. 54, 1480\u20131484 (2012).","journal-title":"Clin. Infect. Dis."},{"key":"382_CR173","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1002\/cncr.23152","volume":"112","author":"R Bensadoun","year":"2008","unstructured":"Bensadoun, R. et al. Comparison of the efficacy and safety of miconazole 50-mg mucoadhesive buccal tablets with miconazole 500-mg gel in the treatment of oropharyngeal candidiasis: A prospective, randomized, single-blind, multicenter, comparative, phase III trial in patients treated with radiotherapy for head and neck cancer. Cancer 112, 204\u2013211 (2008).","journal-title":"Cancer"},{"key":"382_CR174","first-page":"359","volume":"23","author":"C Orvain","year":"2015","unstructured":"Orvain, C. et al. Miconazole mucoadhesive buccal tablet in high-dose therapy with autologous stem cell transplantation (HDT\/ASCT)-induced mucositis. Support. Care Cancer 23, 359\u2013364 (2015).","journal-title":"Support. Care Cancer"},{"key":"382_CR175","first-page":"19","volume":"18","author":"Y Feng","year":"2018","unstructured":"Feng, Y. Clinical observation of recombinant human IL-11 adjuvant therapy for radioactive oral mucosa injury. Electron. J. Gen. Stomatol. 18, 19 (2018).","journal-title":"Electron. J. Gen. Stomatol."},{"key":"382_CR176","first-page":"214","volume":"213","author":"S Zheng","year":"2018","unstructured":"Zheng, S., Hu, X. & Xu, Z. Effect of IL-11 on stomatitis after high dose MTX chemotherapy in children with acute lymphoblastic leukemia. Zhejiang Pract. Med. 213, 214 (2018).","journal-title":"Zhejiang Pract. Med."},{"key":"382_CR177","unstructured":"Pan, Y., Wu, H. & Li, Y. Effect of recombinant human interleukin-11 treatment on prognosis of patients with radiochemoradiotherapy in the treatment of nasopharyngeal carcinoma. J. Clin. Otorhinolaryngol. Head. Neck. Surg. China 31, 945\u2013948 (2017)."},{"key":"382_CR178","doi-asserted-by":"publisher","first-page":"4075","DOI":"10.3390\/nu13114075","volume":"13","author":"B Garc\u00eda-Gozalbo","year":"2021","unstructured":"Garc\u00eda-Gozalbo, B. & Caba\u00f1as-Alite, L. A Narrative Review about Nutritional Management and Prevention of Oral Mucositis in Haematology and Oncology Cancer Patients Undergoing Antineoplastic Treatments. Nutrients 13, 4075 (2021).","journal-title":"Nutrients"},{"key":"382_CR179","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3892\/or.2014.3564","volume":"33","author":"T Tsujimoto","year":"2015","unstructured":"Tsujimoto, T. et al. L-glutamine decreases the severity of mucositis induced by chemoradiotherapy in patients with locally advanced head and neck cancer: A double-blind, randomized, placebo-controlled trial. Oncol. Rep. 33, 33\u201339 (2015).","journal-title":"Oncol. Rep."},{"key":"382_CR180","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1089\/pho.2016.4105","volume":"34","author":"J Tun\u00e9r","year":"2016","unstructured":"Tun\u00e9r, J. & Jenkins, P. A. Parameter Reproducibility in Photobiomodulation. Photomed. Laser Surg. 34, 91\u201392 (2016).","journal-title":"Photomed. Laser Surg."},{"key":"382_CR181","first-page":"5649","volume":"28","author":"TM Campos","year":"2020","unstructured":"Campos, T. M. et al. Photobiomodulation in oral mucositis in patients with head and neck cancer: a systematic review and meta-analysis followed by a cost-effectiveness analysis. Support. Care Cancer 28, 5649\u20135659 (2020).","journal-title":"Support. Care Cancer"},{"key":"382_CR182","first-page":"3721","volume":"30","author":"BM Da Silva","year":"2022","unstructured":"Da Silva, B. M. et al. Most used photobiomodulation dosimetry parameters to treat oral mucositis after preconditioning for hematopoietic stem cell transplantation: systematic review and meta-analysis. Support. Care Cancer 30, 3721\u20133732 (2022).","journal-title":"Support. Care Cancer"},{"key":"382_CR183","first-page":"6495","volume":"29","author":"MB Ramos-Pinto","year":"2021","unstructured":"Ramos-Pinto, M. B. et al. Intraoral versus extraoral photobiomodulation therapy in the prevention of oral mucositis in HSCT patients: a randomized, single-blind, controlled clinical trial. Support. Care Cancer 29, 6495\u20136503 (2021).","journal-title":"Support. Care Cancer"},{"key":"382_CR184","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1089\/pho.2015.4021","volume":"34","author":"NS Treister","year":"2016","unstructured":"Treister, N. S. et al. A Feasibility Study Evaluating Extraoral Photobiomodulation Therapy for Prevention of Mucositis in Pediatric Hematopoietic Cell Transplantation. Photomed. Laser Surg. 34, 178\u2013184 (2016).","journal-title":"Photomed. Laser Surg."},{"key":"382_CR185","doi-asserted-by":"publisher","first-page":"44","DOI":"10.4103\/2277-9175.151254","volume":"4","author":"M Sarvizadeh","year":"2015","unstructured":"Sarvizadeh, M. et al. Morphine mouthwash for the management of oral mucositis in patients with head and neck cancer. Adv. Biomed. Res. 4, 44 (2015).","journal-title":"Adv. Biomed. Res."},{"key":"382_CR186","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1515\/sjpain-2020-0067","volume":"21","author":"AKCS Schaller","year":"2021","unstructured":"Schaller, A. K. C. S., Peterson, A. & B\u00e4ckryd, E. Pain management in patients undergoing radiation therapy for head and neck cancer \u2013 a descriptive study. Scand. J. Pain. 21, 256\u2013265 (2021).","journal-title":"Scand. J. Pain."},{"key":"382_CR187","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1002\/cncr.10938","volume":"95","author":"LCA Cerchietti","year":"2002","unstructured":"Cerchietti, L. C. A. et al. Effect of topical morphine for mucositis-associated pain following concomitant chemoradiotherapy for head and neck carcinoma. Cancer 95, 2230\u20132236 (2002).","journal-title":"Cancer"},{"key":"382_CR188","doi-asserted-by":"publisher","first-page":"786","DOI":"10.2353\/ajpath.2010.090457","volume":"176","author":"JL Martin","year":"2010","unstructured":"Martin, J. L. et al. Chronic Morphine Administration Delays Wound Healing by Inhibiting Immune Cell Recruitment to the Wound Site. Am. J. Pathol. 176, 786\u2013799 (2010).","journal-title":"Am. J. Pathol."},{"key":"382_CR189","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1016\/j.bcp.2009.03.003","volume":"77","author":"JM Rook","year":"2009","unstructured":"Rook, J. M., Hasan, W. & McCarson, K. E. Morphine-induced early delays in wound closure: Involvement of sensory neuropeptides and modification of neurokinin receptor expression. Biochem. Pharmacol. 77, 1747\u20131755 (2009).","journal-title":"Biochem. Pharmacol."},{"key":"382_CR190","first-page":"3611","volume":"17","author":"MH AkhavanKarbassi","year":"2016","unstructured":"AkhavanKarbassi, M. H., Yazdi, M. F., Ahadian, H. & SadrAbad, M. J. Randomized DoubleBlind PlaceboControlled Trial of Propolis for Oral Mucositis in Patients Receiving Chemotherapy for Head and Neck Cancer. Asian Pac. J. Cancer Prev. APJCP 17, 3611\u20133614 (2016).","journal-title":"Asian Pac. J. Cancer Prev. APJCP"},{"key":"382_CR191","doi-asserted-by":"publisher","first-page":"3352","DOI":"10.1039\/D0FO02808H","volume":"12","author":"W An","year":"2021","unstructured":"An, W., Li, S. & Qin, L. Role of honey in preventing radiation-induced oral mucositis: a meta-analysis of randomized controlled trials. Food Funct. 12, 3352\u20133365 (2021).","journal-title":"Food Funct."},{"key":"382_CR192","doi-asserted-by":"publisher","first-page":"4115","DOI":"10.1007\/s00784-020-03743-1","volume":"25","author":"ICGDS Lima","year":"2021","unstructured":"Lima, I. C. G. D. S. et al. Clinical applicability of natural products for prevention and treatment of oral mucositis: a systematic review and meta-analysis. Clin. Oral. Investig. 25, 4115\u20134124 (2021).","journal-title":"Clin. Oral. Investig."},{"key":"382_CR193","doi-asserted-by":"crossref","unstructured":"Toma\u017eevi\u010d, T. & Jazbec, J. A double blind randomised placebo controlled study of propolis (bee glue) effectiveness in the treatment of severe oral mucositis in chemotherapy treated children. Complement. Ther. Med. 21, 306\u2013312 (2013).","DOI":"10.1016\/j.ctim.2013.04.002"},{"key":"382_CR194","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.bjoms.2011.03.005","volume":"50","author":"J Bardy","year":"2012","unstructured":"Bardy, J. et al. A double-blind, placebo-controlled, randomised trial of active manuka honey and standard oral care for radiation-induced oral mucositis. Br. J. Oral. Maxillofac. Surg. 50, 221\u2013226 (2012).","journal-title":"Br. J. Oral. Maxillofac. Surg."},{"key":"382_CR195","first-page":"751","volume":"22","author":"P Hawley","year":"2014","unstructured":"Hawley, P., Hovan, A., McGahan, C. E. & Saunders, D. A randomized placebo-controlled trial of manuka honey for radiation-induced oral mucositis. Support. Care Cancer 22, 751\u2013761 (2014).","journal-title":"Support. Care Cancer"},{"key":"382_CR196","first-page":"5871","volume":"28","author":"RV Lalla","year":"2020","unstructured":"Lalla, R. V. et al. Efficacy and safety of Dentoxol\u00ae in the prevention of radiation-induced oral mucositis in head and neck cancer patients (ESDOM): a randomized, multicenter, double-blind, placebo-controlled, phase II trial. Support. Care Cancer 28, 5871\u20135879 (2020).","journal-title":"Support. Care Cancer"},{"key":"382_CR197","first-page":"1797","volume":"20","author":"RV Lalla","year":"2012","unstructured":"Lalla, R. V. et al. A randomized, double-blind, placebo-controlled trial of misoprostol for oral mucositis secondary to high-dose chemotherapy. Support. Care Cancer 20, 1797\u20131804 (2012).","journal-title":"Support. Care Cancer"}],"container-title":["International Journal of Oral Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41368-025-00382-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41368-025-00382-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41368-025-00382-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T12:36:34Z","timestamp":1757248594000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41368-025-00382-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,15]]},"references-count":197,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["382"],"URL":"https:\/\/doi.org\/10.1038\/s41368-025-00382-8","relation":{},"ISSN":["2049-3169"],"issn-type":[{"value":"2049-3169","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,15]]},"assertion":[{"value":"18 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"54"}}